Allylescaline is a synthetic psychedelic compound from the phenethylamine family and a structural analog of mescaline. Although they share similar chemical frameworks, Allylescaline is a distinct molecule with its own psychoactive properties. It offers a more modern, clean, and accessible experience while preserving some of the core traits associated with mescaline, such as euphoria, visual enhancement, and emotional clarity. This compound is favored among researchers and experienced users looking for a mescaline-type effect with a longer, more stable duration and less physical load.

• Structural Relationship to Mescaline: Allylescaline shares the 3,4,5-trimethoxyphenethylamine core of mescaline but features an allyl group at the 4-position, which alters its binding properties and effects. This small structural tweak significantly changes its psychoactive profile while preserving some of mescaline’s warmth.

• Duration and Onset: Allylescaline typically lasts 8–12 hours, with a slow onset (up to 2 hours), while mescaline can last up to 14 hours with a more rapid body load. This gradual rise makes Allylescaline more manageable and less overwhelming.

• Subjective Effects: While mescaline is deeply introspective and at times emotionally intense, Allylescaline tends to be more euphoric, emotionally neutral, and functional, offering a smoother psychological ride.

• Visuals and Perception: Visual effects with Allylescaline are present but typically milder and more pattern-based than mescaline’s expansive, nature-connected visuals. Allylescaline’s visuals tend to be cleaner and more controlled.

• Body Load and Comfort: Many users report that Allylescaline carries significantly less nausea, cramping, or gastrointestinal discomfort than mescaline, making it easier on the body over long durations.

• Modern Utility: Because it is synthesized in labs, Allylescaline offers consistency in purity and dosage, unlike plant-derived mescaline, which can vary widely in potency depending on the cactus species and preparation method.

• Research Interest: Allylescaline is studied not only for its subjective effects but also for how small structural modifications influence receptor activity within the brain’s serotonergic system.

Proper storage is essential for preserving the potency, stability, and safety of Allylescaline over time. As with all research chemicals, it should be handled with care and stored under conditions that protect it from degradation caused by environmental factors such as light, heat, and moisture.

• Temperature Requirements: Allylescaline should be stored in a cool environment, ideally between 2–8°C. A dedicated laboratory fridge or a stable refrigeration unit is ideal for long-term storage.

• Light Sensitivity: Exposure to UV or direct sunlight can break down the molecular integrity of Allylescaline. Use opaque or amber-colored vials and keep containers inside closed cabinets or boxes to block all light.

• Moisture Protection: Allylescaline is hygroscopic, meaning it can absorb moisture from the air. Always store in airtight containers with a desiccant packet if possible to prevent clumping or chemical changes due to humidity.

• Air Exposure: Limit the amount of time the container is open. Repeated exposure to air may cause oxidation or contamination. Open the container only when measuring and reseal immediately after use.

• Labeling for Research Use: Clearly label all storage containers with the compound’s name, batch number, and date of acquisition. Mark “Not for Human Consumption” to comply with safety guidelines.

• Avoid Cross-Contamination: Never store Allylescaline near volatile or aromatic substances. Even in sealed containers, vapors from other chemicals could alter its profile or contaminate samples.

• Shelf Life Estimate: When properly stored, Allylescaline can remain stable for up to two years. Periodic testing (via NMR or HPLC, for example) is recommended for long-term research applications.

Allylescaline is known for its uplifting, emotionally warm, and visually engaging effects, making it a gentle but sustained psychedelic experience. Reports from researchers and experienced users describe its effects as clean, euphoric, and well-suited for introspection, creativity, or therapeutic-style exploration.

• Emotional Elevation: Allylescaline often induces feelings of serenity, empathy, and calm euphoria. Unlike more chaotic psychedelics, it fosters a sense of comfort and mental clarity.

• Enhanced Sensory Perception: Users consistently report heightened visual sensitivity to colors, soft visual patterning, and greater tactile awareness. These effects are immersive but rarely overwhelming.

• Cognitive Clarity: Unlike LSD, which can cause intense thought loops or hyper-analysis, Allylescaline supports coherent, emotionally grounded thinking. This makes it suitable for philosophical contemplation or self-exploration.

• Physical Sensations: Allylescaline has a pronounced but pleasant body high, often described as light, vibrational, or tingling. Most users report a lack of muscle tension, nausea, or discomfort.

• Social Connectivity: While not inherently empathogenic like MDMA, Allylescaline enhances social openness and smooth communication, especially in comfortable settings or with trusted companions.

• Nature Appreciation: Many find that it amplifies connection with the natural world. Trees, water, and sky often seem to shimmer or feel “alive,” without the depth or intensity of a mescaline journey.

• Creative Enhancement: Allylescaline may facilitate artistic expression, musical appreciation, and imaginative thinking, making it useful for artists or during creative retreats.

While Allylescaline has not undergone clinical safety trials, anecdotal reports suggest that it is relatively safe when used responsibly in low to moderate doses and in proper environments. As with all psychedelics, its safety depends heavily on dosage, setting, and the mental and physical health of the user.

• Low Toxicity Profile: There are currently no known deaths or severe health events directly attributed to Allylescaline when taken in standard research doses. It appears to have a low physiological toxicity.

• No Known Addiction Potential: Allylescaline is not physically addictive and has no reinforcing properties that lead to habitual use. In fact, most users space their experiences due to its long duration.

• Serotonin Receptor Action: Like mescaline, Allylescaline likely works through the 5-HT2A serotonin receptor, which governs psychedelic perception. It does not appear to overstimulate the cardiovascular or central nervous system at moderate doses.

• Interaction Risks: Dangerous interactions may occur if combined with MAO inhibitors, stimulants, or medications like SSRIs. These combinations should be avoided due to potential serotonin overload or cardiovascular stress.

• Mental Health Considerations: Those with a history of schizophrenia, bipolar disorder, or severe anxiety should not use Allylescaline, as it may amplify psychological symptoms or cause destabilization.

• Physical Precautions: Users with cardiovascular issues or epilepsy should avoid use due to potential overstimulation. A medical consultation is advised if underlying conditions are present.

• Tolerability: Unlike some psychedelics that can induce intense or frightening experiences, Allylescaline is typically well-tolerated and rarely associated with “bad trips” when used in supportive environments.

Allylescaline is recognized for its long-lasting but gentle arc of effects, making it ideal for users who prefer extended, smooth experiences. Its timeline includes a slow build-up, a steady and prolonged peak, and a gradual return to baseline with minimal crash or comedown symptoms.

• Onset Time: Effects usually begin 90–150 minutes after ingestion. This slow onset means users must be patient and avoid redosing prematurely, which could lead to overdose.

• Peak Duration: The peak experience typically lasts between 3 to 5 hours, during which users feel the most vivid perceptual changes, emotional elevation, and cognitive enhancement.

• Total Duration: The overall experience ranges from 8 to 12 hours, depending on dosage, metabolism, and whether the compound was taken on an empty stomach.

• Afterglow Effects: Many users report a positive emotional afterglow that lasts up to 24 hours post-experience, characterized by lingering calm, gratitude, and sensory sensitivity.

• Sleep Considerations: Some users are able to sleep comfortably a few hours after the peak ends, while others may experience mild stimulation until effects fully subside.

• Functional Recovery: Most individuals feel fully recovered by the next day, with no residual confusion, fatigue, or emotional unease, which makes Allylescaline more favorable than some alternatives like LSD or 2C-E.

• Re-dosing Caution: Due to its delayed onset and extended duration, Allylescaline should not be re-dosed within the same day. Redosing may result in a longer, less manageable trip or increased side effects.

The legal status of Allylescaline varies across jurisdictions and is often undefined due to its status as a lesser-known research chemical. While it is not explicitly scheduled in most countries, it may fall under analog laws depending on local drug policy. Researchers and users must be aware of their national or regional laws before attempting to purchase, possess, or use Allylescaline.

• Unscheduled in Most Regions: Allylescaline is not listed under international drug control treaties such as the UN’s 1971 Convention on Psychotropic Substances. In many countries, this means it is technically legal unless covered by analog laws.

• Analog Laws in the U.S. and U.K.: In countries like the United States and the United Kingdom, Allylescaline may be considered an analog of mescaline or other phenethylamines, making its possession prosecutable if intended for human consumption.

• Legally Sold as a Research Chemical: Most suppliers, including Psycho Plug, sell Allylescaline under research or analytical use designations. This distinction protects both the seller and buyer in jurisdictions where analog law interpretation is more lenient.

• Import Restrictions: Customs regulations vary. While some countries allow importation of unscheduled compounds, others may seize the package if it resembles controlled substances chemically or visually.

• Buyer’s Responsibility: Customers must confirm the legality of Allylescaline in their own region before ordering. Psycho Plug cannot be held liable for seizures or legal issues arising from misuse or misinterpretation of local laws.

• Private Use Gray Area: In countries without analog legislation, personal research or non-commercial possession may go unregulated, but this is not a guarantee of safety from law enforcement scrutiny.

• Documentation Support: We provide generic labeling and research-use documentation to help reduce legal exposure during shipping or customs inspections.

Allylescaline is active at relatively low doses compared to classic psychedelics. Because of its long duration and slow onset, accurate dosing is essential to ensure a safe and manageable experience. Always begin with a conservative dose, especially for first-time users or researchers unfamiliar with phenethylamines.

• Threshold Dose (5–10 mg): Minimal perceptual and emotional effects may be noticed. This dose is suitable for sensitivity testing or analytical evaluation.

• Light Dose (10–20 mg): Gentle euphoria, subtle visual enhancements, and enhanced cognition. Ideal for cautious first-time use or functional settings.

• Moderate Dose (20–35 mg): Full psychedelic effects including open and closed-eye visuals, emotional uplift, and introspective thought patterns. Considered a standard dose range for experienced users.

• High Dose (35–50 mg): Intensified visuals, deeper emotional shifts, stronger body high, and extended duration. Should only be taken by those with prior experience.

• Very High Dose (50+ mg): Not recommended except under controlled laboratory conditions. Risk of overstimulation, nausea, or difficulty managing duration increases significantly.

• Accurate Measurement is Critical: Always use a calibrated milligram scale. Eye-balling doses can lead to dangerous overuse, especially with research-grade powders.

• No Redosing Rule: Because Allylescaline takes 1.5 to 2 hours to come on fully, redosing during the early phase is discouraged. Overlapping doses can result in unpredictably strong or prolonged trips.

Combining Allylescaline with other substances introduces both risks and opportunities, depending on the compounds involved and the user’s experience level. While some combinations may enhance the experience, others may increase the likelihood of adverse effects or toxic interactions. Responsible experimentation, if conducted at all, should be preceded by thorough research.

• Cannabis: May enhance visuals and emotional sensitivity, especially during the peak phase. However, it can also increase anxiety or paranoia in sensitive individuals, particularly during the onset.

• MDMA and Empathogens: Combining Allylescaline with MDMA can intensify emotional and tactile sensations, but also increases the risk of serotonin syndrome and cardiovascular strain. This combo should be approached with extreme caution or avoided altogether.

• LSD or Other Psychedelics: Stacking Allylescaline with LSD or psilocybin can create unpredictable effects, possibly extending duration or creating sensory overload. The synergy is poorly documented and generally discouraged.

• Alcohol: Using alcohol alongside Allylescaline may dull the psychedelic effects but can also increase dehydration, nausea, and body load. It may also impair judgment during an otherwise clear-headed trip.

• MAOIs (Monoamine Oxidase Inhibitors): Strongly contraindicated. This combination can lead to dangerous cardiovascular or neurological events and must be strictly avoided.

• SSRIs (Selective Serotonin Reuptake Inhibitors): May reduce the effects of Allylescaline due to serotonin receptor saturation. Some users on SSRIs may not feel any effect at all, while others may experience blunted visuals and mood response.

• Benzodiazepines: Can be used as a safety net to reduce anxiety or end a difficult experience, but should not be combined preemptively. Only to be used under proper knowledge of interaction timing and effects.

At Psycho Plug, we supply Allylescaline in its most stable, research-friendly form: a high-purity crystalline powder. This form offers maximum flexibility for measurement, storage, and precise application in controlled research environments. It is not prepared for consumption and is sold strictly for scientific and analytical use.

• Crystalline Powder: Fine, white to off-white in appearance. Easily handled using micro-spatulas or lab-grade scoops. Has minimal odor and no taste.

• Lab-Tested Purity: Each batch is ≥98% pure, verified through third-party lab testing using methods like HPLC or NMR. This ensures consistent results for both scientific replication and subjective evaluation.

• Packaged for Preservation: Supplied in heat-sealed, vacuum-packed mylar bags to prevent exposure to air, moisture, and contaminants during transit and storage.

• Weighed in Precision Amounts: Offered in standard quantities of 250mg, 500mg, 1g, and up to 10g. Custom bulk sizes are also available upon request.

• Labeled as a Research Chemical: All packages are discreetly marked for laboratory or educational use only, without any psychoactive indications.

• Stable for Long-Term Storage: When kept in ideal storage conditions (cool, dark, dry), the powdered form remains chemically stable for up to two years.

• No Fillers or Additives: Our Allylescaline is not mixed with bulking agents, binding compounds, or cutting materials. It is pure and unadulterated.

Allylescaline appeals to a variety of users, especially within the research and psychonaut communities. Its distinctive effects—gentle, long-lasting, and euphoric—make it attractive to individuals seeking a cleaner alternative to mescaline, as well as those involved in the exploration of psychedelic analogs and neurochemical behavior.

• Independent Researchers: Chemistry professionals and psychopharmacologists use Allylescaline to study structure-activity relationships among mescaline analogs, serotonin receptors, and phenethylamines.

• Psychonauts and Experienced Users: Individuals with extensive psychedelic experience often explore Allylescaline to compare its subjective effects to more common compounds like 2C-B or LSD.

• Artists and Creatives: Its sustained, calm euphoria and enhanced sensory perception make Allylescaline a popular choice for visual artists, musicians, and writers seeking flow states.

• Nature Enthusiasts: The compound’s affinity for enhancing natural beauty and sensory harmony appeals to those engaging in wilderness journeys, retreats, or meditative outdoor sessions.

• Therapeutic Context (Unofficial): While not clinically approved, some people explore Allylescaline in therapeutic-style environments for emotional release, reflection, and trauma processing. Always with caution and preparation.

• Forensic Analysts and Academic Labs: Allylescaline serves as a subject in research involving receptor binding, brain imaging, or toxicity profiling for phenethylamine derivatives.

• Curiosity-Driven Users: Those with a safe and informed interest in less mainstream psychedelics may turn to Allylescaline for novelty and exploration of uncharted experiential territory.

Allylescaline is often described as a gentle and emotionally warm psychedelic, but its long duration and delayed onset can present challenges for those new to psychedelics. While not overly intense or visually overwhelming, it is best approached cautiously by first-time users due to its duration and subtle onset.

• Long Duration May Be Intimidating: For beginners, an 8–12 hour trip can be difficult to manage without prior experience. A compound that lasts this long requires planning and mental stamina.

• Delayed Onset Can Lead to Redosing Mistakes: Because Allylescaline takes up to 2 hours to take full effect, inexperienced users may misjudge and redose prematurely, increasing the risk of overwhelming effects.

• Emotionally Gentle Profile: Compared to LSD or psilocybin, Allylescaline rarely triggers intense fear, confusion, or ego dissolution. This makes it more approachable for beginners who want a less jarring experience.

• Clarity Over Complexity: Allylescaline supports coherent thinking and mood stability rather than the intense cognitive spirals common with classic psychedelics, which is a benefit for those unfamiliar with altered states.

• Best Used with a Sitter or Guide: First-time users should have a trusted, sober friend or guide present. This ensures emotional and physical safety over the long duration.

• Low Dose Strongly Recommended: Beginners should never exceed 15–20 mg. Starting small allows observation and adjustment in future sessions.

• Ideal for Outdoor or Controlled Settings: The compound works well in quiet, natural environments. Beginners should avoid chaotic or unfamiliar settings to reduce the chance of sensory overload.

Allylescaline shares some common ground with LSD and psilocybin—especially in its capacity to alter perception and enhance sensory awareness—but it stands apart in several important ways. It offers a more stable emotional baseline, longer onset, and a cleaner body load, making it appealing for users seeking a more relaxed and digestible psychedelic experience.

• Duration Similar to LSD, Longer Than Psilocybin: Allylescaline typically lasts 8–12 hours, like LSD, while psilocybin experiences usually last 4–6 hours. The extended timeline makes it more demanding than mushrooms but smoother than LSD.

• Visuals Are Milder and Softer: Compared to LSD’s sharp, geometric visuals and psilocybin’s organic, flowing patterns, Allylescaline offers more subtle enhancement—color saturation, movement in surfaces, and light warping—without intense hallucinations.

• Emotional Landscape Is More Neutral: While psilocybin can induce deep emotional waves and LSD often prompts intense analytical thought, Allylescaline maintains a stable, euphoric mood that doesn’t overwhelm.

• Body Load and Physical Experience: Allylescaline is less taxing on the body than LSD (which can cause tension) or mushrooms (which may cause nausea or digestive discomfort). It provides a gentle body high often described as relaxing.

• Cognitive Clarity: Allylescaline is less likely to cause racing thoughts or existential introspection. LSD is known for triggering intense mental journeys, while Allylescaline offers more cognitive coherence and control.

• Spiritual vs. Functional Use: Psilocybin is often described as deeply spiritual, while LSD leans analytical. Allylescaline occupies a middle ground—empathic, clear, and aesthetically pleasing, but without a strong spiritual narrative.

• Less Risk of Challenging Trips: Due to its gentle nature, Allylescaline is less likely to induce fear, paranoia, or overwhelming thoughts, which can occur with both LSD and mushrooms under certain conditions.

Allylescaline is well-tolerated physically in most cases, but as with any psychoactive compound, side effects can occur—especially with higher doses or poor preparation. These effects are generally mild and manageable, though individual responses can vary.

• Dilated Pupils: A common and harmless effect, this may increase light sensitivity, particularly in bright environments. Sunglasses may help mitigate discomfort outdoors.

• Mild Nausea or GI Discomfort: Some users experience slight stomach upset during onset, especially if taken after a meal. Fasting for a few hours beforehand may reduce this.

• Increased Heart Rate or Blood Pressure: Slight cardiovascular stimulation may occur, especially during the come-up. Generally mild but should be monitored in individuals with heart conditions.

• Muscle Tension or Jaw Clenching: Rare but possible, particularly in users prone to tension during stimulation. Magnesium supplements or gentle stretching may help.

• Body Temperature Fluctuations: Some users report feeling cold or warm intermittently. Light clothing layering is recommended to manage comfort.

• Dry Mouth: A common symptom, easily mitigated with water or herbal teas. Staying hydrated is advised throughout the experience.

• Insomnia or Difficulty Sleeping Post-Trip: Due to the long duration and slight stimulation, users may find it difficult to sleep immediately after the effects wear off.

Although Allylescaline is considered one of the more forgiving psychedelics in terms of emotional impact, it is still a potent mind-altering substance. Under the wrong conditions—such as poor setting, mental distress, or excessive dosing—it can produce challenging or uncomfortable experiences.

• Set and Setting Still Matter: As with all psychedelics, your mindset and environment are crucial. Using Allylescaline while anxious, sad, or in a chaotic space can lead to negative emotional loops.

• Overdosing Can Lead to Overwhelm: Taking too high a dose may result in confusion, physical restlessness, or emotional fatigue. Respect the potency and use accurate measurement tools.

• Fear or Anxiety May Still Arise: Even with its gentle profile, some users may feel lost, disoriented, or anxious—especially during the long onset or peak if they feel unprepared.

• Sensory Overload in Public Settings: Bright lights, loud noises, or crowds can become overwhelming. Controlled, quiet, and safe spaces are ideal.

• Social Discomfort: Conversations or interactions may feel awkward or exaggerated. It’s best to be with trusted individuals or alone in a peaceful environment.

• Use of a Sitter Helps Mitigate Risk: Having a calm, sober, experienced person nearby can be a grounding force if anxiety or confusion arises during the trip.

• Grounding Techniques Can Help: Deep breathing, hydration, calming music, and shifting focus to physical sensations can reduce feelings of panic or spiraling thoughts.

Allylescaline is a relatively recent compound in the psychedelic landscape, known primarily due to its inclusion in the renowned chemical compendium PiHKAL by Dr. Alexander Shulgin. Although not as historically significant as mescaline or LSD, Allylescaline represents a significant milestone in the exploration of synthetic phenethylamines.

• Synthesized by Alexander Shulgin: Allylescaline was one of many compounds synthesized by Dr. Shulgin during his career exploring structural modifications of psychedelic phenethylamines. It appears in PiHKAL (Phenethylamines I Have Known and Loved) under entry #10.

• Created for Structure-Activity Research: Shulgin designed Allylescaline to investigate how small chemical modifications—like adding an allyl group—could affect psychoactive potency and receptor interaction compared to mescaline.

• Limited Traditional Use: Unlike mescaline, which has been used ceremonially by Indigenous cultures for centuries, Allylescaline has no traditional or ancient ethnobotanical history. It is a modern, lab-synthesized analog.

• Underground Popularity: Over the past two decades, Allylescaline has gained modest traction in the research and psychonaut communities due to its unique blend of clarity, calm, and long duration.

• Not Commercially Explored: There are no pharmaceutical or therapeutic clinical trials currently underway for Allylescaline, limiting its documentation to anecdotal reports and underground research.

• Contributes to the Legacy of PiHKAL: Shulgin’s work on Allylescaline is part of a broader legacy that includes hundreds of novel psychedelic compounds, many of which remain under-researched but are foundational to modern psychopharmacology.